# C4 Therapeutics, Inc.: Form 8-K/A, filed Sep 22, 2022

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K/A
- Filed: 2022-09-22
- Accepted by EDGAR: Sep 22, 2022, 07:41 ET
- Period: 2022-06-22
- Accession: 0001628280-22-025322
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000162828022025322/cccc-20220622.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000162828022025322/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000162828022025322/cccc-20220622.htm

Filed Sep 22, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-025322. Last ingested by Listed: Nov 5, 2026, 12:02 ET. No prices; not investment advice.